Roche Diagnostics cobas® 4800 and cobas® 6800
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
CDC OFFICE OF ACQUISITION SERVICES
Contract Value
Not provided
Codes & Classification
Solicitation Number
2026-Q-98331
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
6640
Additional Details
Documents2
The Centers for Disease Control and Prevention (CDC), through its Office of Acquisition Services, has issued a combined synopsis/solicitation for the procurement of maintenance services for Roche Diagnostics cobas® 4800 and cobas® 6800 laboratory equipment. This requirement originates from the National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) International Laboratory Branch, with services to be performed in Atlanta, Georgia.
The primary objective of this procurement is to secure ongoing, reliable maintenance for the Roche cobas® 4800 and 6800 instruments, which are critical to the laboratory’s diagnostic and research operations. The intended outcome is to ensure uninterrupted functionality, compliance with manufacturer standards, and preservation of equipment warranties and guarantees. The maintenance services will encompass all necessary repairs, replacements, and technical support as authorized by the original equipment manufacturer.
This acquisition is being conducted as a firm-fixed price, sole source procurement under the authority of FAR Part 5.203 and FAR Part 12.102(a). Roche Diagnostics Corporation, located at 9115 Hague Road, Indianapolis, Indiana, is identified as the only source capable of providing these services due to proprietary manufacturing processes and exclusive authorization for maintenance of their equipment. Engaging any other service provider would void existing warranties and could compromise the operational integrity of the laboratory’s instruments.
The procurement is classified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) and Product Service Code 6640. There are no set-aside provisions associated with this notice; it is open to all responsible sources, though the justification for sole source is based on the unique capabilities of Roche Diagnostics Corporation.
Interested parties who believe they can fulfill the requirements are encouraged to submit a written capability statement to the Contracting Officer by the response deadline of July 28, 2026. All inquiries and submissions must be in writing and directed to Debra Baker at [email protected], referencing solicitation #2026-Q-98331. Secondary contact is Liubov Kriel at [email protected]. The government will consider all responses solely for the purpose of determining whether to conduct a competitive procurement; the final decision rests at the discretion of the Contracting Officer.
This notice remains active and is posted on SAM.gov under Opportunity ID 4d61615e163047d69776ffe256494c09. Additional details and attachments are available via the provided notice URL.
Contractors evaluating this opportunity should note the specialized nature of the requirement, the sole source justification, and the critical importance of maintaining manufacturer authorization to ensure compliance and equipment integrity throughout the contract lifecycle.